• LAST PRICE
    0.8000
  • TODAY'S CHANGE (%)
    Trending Down-0.0290 (-3.4982%)
  • Bid / Lots
    0.8000/ 1
  • Ask / Lots
    0.8600/ 410
  • Open / Previous Close
    0.8400 / 0.8290
  • Day Range
    Low 0.8000
    High 0.8473
  • 52 Week Range
    Low 0.7030
    High 5.4500
  • Volume
    30,780
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 0.829
TimeVolumeAVGR
09:32 ET5730.84
09:33 ET8000.84
09:39 ET29040.834
09:50 ET10000.834
09:53 ET1220.8301
10:08 ET9950.8301
10:09 ET19140.8315
10:29 ET1000.8301
10:45 ET18330.82
10:51 ET98940.81
11:14 ET1250.8196
11:36 ET15000.8473
11:38 ET1180.833
12:14 ET10000.83
12:48 ET11900.8101
01:22 ET19240.815701
01:38 ET2250.8299
02:59 ET1000.8281
03:08 ET19780.8
04:00 ET2670.8
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAVGR
Avinger Inc
2.7M
-0.1x
---
United StatesRSLS
ReShape Lifesciences Inc
2.8M
-0.3x
---
United StatesMDIT
Medite Cancer Diagnostics Inc
90.0
0.0x
---
United StatesAPYI
Arypsa Inc
30.0
0.0x
---
United StatesNUWE
Nuwellis Inc
5.3M
0.0x
---
United StatesVIVE
Viveve Medical Inc
4.3K
0.0x
---
As of 2024-11-26

Company Information

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).

Contact Information

Headquarters
400 Chesapeake DrREDWOOD CITY, CA, United States 94063-4739
Phone
650-363-2400
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
James Cullen
President, Chief Executive Officer, Director
Jeffrey Soinski
Chief Financial Officer, Chief Accounting Officer, Vice President - Finance
Nabeel Subainati
Chief Technology Officer
Himanshu Patel
Director
Zhong Zhao

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.7M
Revenue (TTM)
$7.3M
Shares Outstanding
3.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.14
EPS
$-11.03
Book Value
$-4.85
P/E Ratio
-0.1x
Price/Sales (TTM)
0.4
Price/Cash Flow (TTM)
---
Operating Margin
-240.98%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.